Homeopathic Treatment in Patients with COVID-19: Analysis of Clinical Evolution and Comparison between Cases in 2020 and 2021.
| Autor: | Fujino FMSDC; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Olandim AACC; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Coggan JA; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Carvalho Junior AD; Computer Science Department, Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil., Bufalo AQS; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Takeyama EN; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Sant'Ana SC; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Barnabé VD; Department of Medicine, George Galvão Hahnemannian Institute (IHGG), São Paulo, Brazil., Benites NR; Department of Preventive Veterinary Medicine and Animal Health (VPS), University of São Paulo, School of Veterinary Medicine and Animal Science, São Paulo, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Homeopathy : the journal of the Faculty of Homeopathy [Homeopathy] 2023 Feb; Vol. 112 (1), pp. 3-11. Date of Electronic Publication: 2022 Sep 01. |
| DOI: | 10.1055/s-0042-1749447 |
| Abstrakt: | Background: The manifestations of coronavirus disease 2019 (COVID-19) can result in several prognoses and lead patients to look for appropriate complementary or alternative treatment options according to their personal situation and available health care. Patients with mild symptoms or those who have not yet reached the maximum severity of their condition are those who seek outpatient care, where homeopathic treatment might be considered, given the well documented history of this medical system in several epidemics in the past. Objective: The aim of this study was to compare the homeopathic treatment used for symptomatic cases of COVID-19 in March and April 2020 with cases treated in March and April 2021. Method: This is a retrospective observational study based on the analysis of the medical records of symptomatic COVID-19 patients treated on an outpatient basis with homeopathy at the Hahnemanniano George Galvão Institute in São Paulo, Brazil. We analyzed 54 cases, divided into two samples (27 cases in each year), similar in relation to age, gender and origin of the patients. Results: The development was distinct in the 2 years, with improvement of symptoms after 3 days of the first homeopathic prescription in 2020 whilst in 2021 the improvement occurred from the sixth day onward. The most frequently prescribed homeopathic medicine also differed in the two samples ( Antimonium tartaricum in 2020; Arsenicum album in 2021), which indicates the different disease characteristics at these two moments of the epidemic. Conclusion: In 2020, the symptomatology of the cases was mainly acute and the main medicine was Antimonium tartaricum . By comparison, in 2021 a greater interference from individuals' previous chronic miasmatic disease may explain the change in the main medicines used that year, with Arsenicum album being the most prescribed in the cases studied. Competing Interests: None declared. (Faculty of Homeopathy. This article is published by Thieme.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|